You are about to leave the Clinical Value website now.

Cancel

Recent Articles

27 June 2024

The implications of identifying and managing HCC surveillance patients in General Practice

9 December 2022

Liver Disease in Asia Pacific: Insights from Prof Pierce Chow

In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical…

READ MORE
9 December 2022

Liver Cancer in Japan: Dr Shun Kaneko on HCC Screening and Surveillance

Japan is a global leader in hepatocellular carcinoma (HCC) surveillance, with an effective programme that enables early-stage carcinomas detection. Yet unmet needs continue to affect the…

READ MORE
9 December 2022

Strengthening healthcare systems through the critical role of diagnostics

In line with the WHO Essential Diagnostics List (EDL) and Lancet Commission efforts, the Asia Pacific Medical Technology Association and its members recently came together to…

READ MORE

You May Also Like

14 June 2024

Empowering Healthcare Professionals to Combat Liver Cancer in Australia

Read More

Be the first to receive updates, event opportunities, and thought leadership insights.